Emerging opportunistic yeast infections (Q37832837)

24 August 2017

1 reference

title

Emerging opportunistic yeast infections (English)

1 reference

24 August 2017

Marisa H Miceli

1

1 reference

24 August 2017

José A Díaz

series ordinal

2

1 reference

24 August 2017

Samuel A Lee

series ordinal

3

1 reference

24 August 2017

publication date

1 February 2011

1 reference

Lancet Infectious Diseases

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

142-151

1 reference

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Rhodotorula glutinis fungemia in a liver-kidney transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Saccharomyces cerevisiae fungemia: an emerging infectious disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Shifting patterns in the epidemiology of nosocomial Candida infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Active surveillance for candidemia, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida parapsilosis, an emerging fungal pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

IsCandida kefyran Emerging Pathogen in Patients with Oncohematological Diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Biogeography of the yeasts of ephemeral flowers and their insects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida biofilms: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Biofilms of non-Candida albicans Candidaspecies: quantification, structure and matrix composition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida lusitaniae infections in the era of fluconazole availability

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Guidelines for the management of intravascular catheter-related infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Emerging and less common fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Summer-type hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Infections due to emerging and uncommon medically important fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Echinocandin antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Fatal Trichosporon fungemia in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Rhodotorula infection. A systematic review of 128 cases from literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Moulds, yeasts and aerobic plate counts in ginseng supplements.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Moulds and yeasts in fruit salads and fruit juices

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Activities of available and investigational antifungal agents against rhodotorula species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Non-neoformans cryptococcal infections: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

First report of Cryptococcus albidus--induced disseminated cryptococcosis in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Nosocomial infection in newborns by Pichia anomala in a Brazilian intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Fungaemia caused by Hansenula anomala--an outbreak in a cancer hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Infection and colonisation of neonates by Hansenula anomala

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Yeasts from human sources

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Pichia anomala fungaemia in immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

The spectrum of Malassezia infections in the bone marrow transplant population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Mixed fungemia: incidence, risk factors, and mortality in a general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

The immune response to fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Differentiation and function of Th17 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Immune reconstitution syndrome associated with opportunistic mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Significance of aspergillemia in patients with cancer: a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Nosocomial candiduria: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Risk factors for candidaemia in critically ill patients: a prospective surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Non-culture-based diagnostics for opportunistic fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Approach to the diagnosis of invasive aspergillosis and candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Molecular mechanism of hemolymph clotting system in Limulus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Differences in beta-glucan levels in culture supernatants of a variety of fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

Revisiting the Source of Candidemia: Skin or Gut?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970218-8

7 January 2021

10.1016/S1473-3099(10)70218-8

Identifiers

DOI

1 reference

24 August 2017

1 reference